Devices to Control Hemorrhage

To stop postpartum hemorrhage

Treatment
Treatment
  • PREVENTION
  • DIAGNOSTIC
  • TREATMENT
  • OVERVIEW
  • TECHNOLOGY Characteristics
  • Devices to Control Hemorrhage
    Rusch Balloon & Catheter

    Global annual deaths associated with hemorrhage

    PERCENT (%)
    NUMBER

    Maternal

    45%
    115,000

    Neonatal

    Stillbirth

     

    Condition:

    Postpartum Hemorrhage (PPH) is bleeding greater than 500 ml occurring in the first 24 hours after delivery. This bleeding can become severe and life threatening, causing about 100,000 deaths per year. The great majority of these deaths occur in low-resource settings, where diagnosis and treatment are more difficult while the women also more often have complicating factors like anemia.

     

    Mechanism of Action:

    After the use of uterotonics and before the removal of the mother's uterus by hysterectomy, further interventions may be necessary to stop the bleeding.  A second treatment method, balloon tamponade, applies direct pressure to the uterus which slows and stops blood flow. It does this both by decreasing the total blood flow through pressure and by allowing the blood conditions suitable for clot formation.

     

    Current use in High-Resource Settings:
    Uterotonics, direct pressure, and hysterectomy are more common in high-resource settings.  The balloon tamponade has some use in uncontrolled traumatic uterine bleeding, and is being used more frequently for uterine atony.  

     

    Current use in Low-Resource Settings:

    Practice in low-resource contexts varies from uterine massage and uterotonics to hysterectomy or other surgery. All these procedures can contribute to slowing PPH. Balloon tamponade is not common at many hospitals, but has been suggested for use in low-resource settings as it can be used by relatively low skilled health providers and successfully stops many cases of postpartum hemorrhage. The device used varies from the relatively high cost Bakri or Blakemore balloons to less expensive options and even the combination of a catheter, condom, and bag of saline.

    REPRESENTATIVE DEVICES

    MAKE
    MODEL
    PRICE
    TECH
    STATUS
    NOTES

    Bakri

    Bakri Balloon
    $250
    With Lumen
    Marketed
    Designed for uterus

    Sengstaken-Blakemore

    Balloon and Catheter
    unknown
    With Lumen
    Marketed
    For upper GI tract

    Rusch

    Balloon
    $100
    With Lumen
    Marketed
    For urinary tract

    Generic

    Condom & Catheter
    <$10
    Condom & salene
    user made
    No lumen for drainage

  • CHARACTERISTICS OF REPRESENTATIVE PRODUCT

    Technology Characteristics

    Operation Parameters

    SKILLS

    REQUIRED

    Intended end user
    Training required
    Time required per use
    Physician, maybe a nurse, and possibly a skilled birth attendant
    Hours
    <30 minutes

    ENVIRONMENT/ INFRASTRUCTURE

    Power required
    Waste collection
    Complementary technologies required
    Temperature and storage
    Maintenance
    None
    Biological Waste
    Saline
    No requirement
    No maintenance

    COST

    Device cost (approximate)
    Cost/course (approximate)
    <$10 for condom based tamponade
    <$10

    OTHER

    Portability
    Regulatory
    Efficacy
    <1lb + saline
    User assembled
    Condom catheter stopped 23/23 hemorrhage cases within 15 minutes in one study.

Sources: Johanson, R., Kumar, M., Obhrai, M. and Young, P. (2001), Management of massive postpartum haemorrhage: use of a hydrostatic balloon catheter to avoid laparotomy. BJOG: An International Journal of Obstetrics & Gynaecology, 108: 420–422. doi: 10.1111/j.1471-0528.2001.00102.x. Balloon tamponade in the management of postpartum haemorrhage: a review. Georgiou C. BJOG an international journal of obstetrics and gynaecology http://www.ncbi.nlm.nih.gov/pubmed/19432563 http://www.ncbi.nlm.nih.gov/pubmed/18704777 http://www.aafp.org/afp/2007/0315/p875.html http://emedicine.medscape.com/article/796785-treatment#a1126 Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD003249. DOI: 10.1002/14651858.CD003249.pub2. http://f1000.com/1163772